We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Irvine Scientific Will Now Offer Sunlight Medical Pipettes in the United States
SANTA ANA, California October 24, 2017: Irvine Scientific, a world leader in the innovation, development, and manufacture of Assisted Reproductive Technologies (ART), today announced a new agreement with Sunlight Medical Inc., which gives Irvine Scientific exclusive US distribution rights for Sunlight Medical branded micropipettes.
Irvine Scientific aims to deliver the highest quality products for in vitro fertilization. With the increased need for intracytoplasmic sperm injection (ICSI) and pre-implantation genetic diagnosis (PGD), the addition of Sunlight Medical micropipettes positions Irvine Scientific to better support the ART community in the complex micromanipulation of gametes and embryos required for ICSI and PGD, as well additional micromanipulation procedures, including assisted hatching and transferring.
The inclusion of Sunlight Medical micropipettes to Irvine Scientific’s product portfolio ensures the Company supplies complete solutions to address the specific needs of the ART community.
“We’re pleased to offer our clients Sunlight Medical’s pipettes because the company shares our passion for exceptional quality and attention to detail,” said Marc Brignola, Head of Worldwide Sales and Marketing - Assisted Reproductive Technology at Irvine Scientific. “By delivering the industry’s foremost media and micropipettes together, Irvine Scientific will help ART laboratories achieve the consistency and precision critical for successful ICSI and PGD, as well as other micromanipulation procedures.”
Sunlight Medical micropipettes complement Irvine Scientific’s micromanipulation media suite, which includes Hyaluronidase, Polyvinylpyrrolidone (PVP), and Multipurpose Handling Medium®.
“Sunlight Medical is well-known as the industry leader for high-quality, handcrafted micropipettes,” noted Dunsong Yang, Chief Executive Officer at Sunlight Medical. “With Irvine Scientific as our distribution partner, we will be better able to deliver to our customers the quality and consistency they rely on.”
All Sunlight Medical pipettes are individually examined to ensure consistent quality. The wide range of specifications available means customers have the option to choose the pipette that best suits their preferences for ICSI and PGD procedures.
For more information visit http://www.irvinesci.com/assisted-reproductive-technology
Notes to Editors
About Irvine Scientific
Irvine Scientific, a member of JXTG Group, is a worldwide leader in the innovation and manufacture of cell culture media, reagents, and medical devices for researchers and clinicians. The company provides unrivaled service and quality to scientists working in cell therapy and regenerative medicine, assisted reproductive technology and cytogenetics, and industrial cell culture for the large-scale production of biotherapeutics and vaccines. Irvine Scientific adheres to both ISO and FDA regulations and operates dual cGMP manufacturing facilities in California, USA and Tokyo, Japan. The company’s consultative philosophy combined with expertise in cell culture and compliance provides customers with unique capabilities and support. For over 45 years, Irvine Scientific has remained uniquely flexible and focused on media while becoming a strategic global leader in media products and services.
About Sunlight Medical
Sunlight Medical Inc manufactures and supplies a complete line of micropipettes for in vitro fertilization (IVF) procedures such as intracytoplasmic sperm injection (ICSI), embryo biopsy, assisted hatching, and other related procedures.
Photo: For a high-resolution photo, please contact lorna.cuddon@zymecommunications.com
Media contacts
Lori Serles, Irvine Scientific
Phone: 949-261-7800 x145
Email: lserles@irvinesci.com
Lorna Cuddon, Zyme Communications
Phone: +44 (0)7811996942
Email: lorna.cuddon@zymecommunications.com
